Proprietary Research
Latest Insights on this Mandate
Read market commentary, sector deep-dives, and quarterly letters from our portfolio managers.
Exposure to innovation across pharmaceuticals, medical technology and life sciences research.
14.0%
annualised return since inception
Moderate–High
2022
Track record established
Health Sciences
Specialist allocation
How our investment team analyzes opportunities, evaluates competitive moats, and manages risk.
To grow capital by investing across the healthcare value chain, from diagnostics and devices through to therapeutics.
Clinical and regulatory catalysts create some of the market's sharpest mispricing. We build a research process around understanding trial data and regulatory pathways as rigorously as the science itself.
Diversified across pharmaceuticals, medical devices, diagnostics and life-sciences tools, balancing established franchises against earlier-stage names with defined catalysts.
Current target exposures across geographies and industry verticals based on fundamental conviction.
United States
52%
Europe
26%
Japan
12%
Rest of world
10%
Pharmaceuticals
31%
Medical devices
24%
Life-science tools
20%
Diagnostics
15%
Other
10%
Comparing strategy return performance against broader benchmark indices over time.
Strategy: 146
Benchmark: 128
Illustrative strategy performance. Past performance is not a reliable indicator of future performance.
This strategy invests in high-conviction equities where valuations and returns can fluctuate over short-to-medium cycles. Sizing is governed by margin of safety and disciplined capital preservation criteria.
Investors seeking long-term capital appreciation over a 5+ year horizon.
High-conviction, bottom-up fundamental strategy independent of benchmark weightings.
Tolerance for short-to-medium term equity market fluctuations.
Access via wholesale/institutional direct mandates or major custodial platforms.
Managed collectively by our senior research analysts and portfolio directors under a unified bottom-up decision framework.
Structured for institutions, wealth managers, and qualified individual investors.
Open and manage your account online with verified digital onboarding.
Available on major custodial and investment reporting platforms.
Read market commentary, sector deep-dives, and quarterly letters from our portfolio managers.
Speak with our client engagement team or start your investment application online.
